Head of Biogen's copycat drug unit leaves to join Scangos startup
The head of a Biogen division that makes biosimilars — cheaper, knockoff versions of popular biologic drugs — has left the Cambridge firm to become the chief operating officer of a startup led by former Biogen CEO George Scangos.
Alpna Seth, who spent nearly two decades at Biogen (Nasdaq: BIIB), including the last three years as senior vice presi dent and global head of the biosimilars unit in Switzerland, left the company sometime in July and joined San Francisco-based Vir Biotechnology earlier…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Max Stendahl Source Type: news